Clinical Trial Update: A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating WX-0593 in advanced solid tumors and non-small cell lung cancer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumor

Drugs mentioned

• WX-0593

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumor, Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN